Search filters

Ricoh acquires Lake Solutions AG

The world-wide active Ricoh technology group acquires all shares in Lake Solutions AG, a leading Swiss ICT solutions Provider.

VISCHER advises the selling shareholders. The team is led by Felix W. Egli (Partner, Corporate/M&A)...

NUMAB concludes Licensing and Development Agreement in China

Suzhou, China and Pfäffikon SZ, Switzerland May 2, 2019 – CStone Pharmaceuticals ("CStone"; HKEX: 2616) and Numab Therapeutics AG ("Numab") have entered into an exclusive regional licensing agreement for the development and...

ALENTIS Therapeutics raises CHF 12.5m in Series A Financing

ALENTIS Therapeutics, a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer, announced today the completion of a Series A financing of CHF 12.5 million. ALENTIS’ lead program is a...

Polyneuron raises CHF 22.5 million in a major Series A financing

Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, today announced the closing of an oversubscribed CHF22.5 million Series A financing. The round was...

USD 100 million debt financing by Hercules Capital to Urovant Sciences

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, has entered into a debt financing agreement with Hercules Capital,...

Arvelle Therapeutics raises USD 180 million in Series A financing

A global syndicate of investors led by LSP and including NovaQuest, BRV Capital Management, Andera Partners, and H.I.G. BioHealth Partners supported new company Arvelle Therapeutics with a USD 180 million financing to acquire the...

Anaveon closes CHF 35 m Series A financing

Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by the Novartis Venture Fund. The company was founded with financing from BaseLaunch,...

Privet Fund Management acquires Hardinge Inc.

Privet Fund Management LLC acquired Hardinge Inc., a leading global provider of advanced metal-cutting machine tool solutions and accessories. Under the terms of the agreement, Privet acquired all shares of Hardinge common stock...

Asset Tokens - Tax Ruling for stamp duty and withholding tax

One of our clients has announced to launch an ICO of Asset Tokens. The Federal Tax Administration took our tax ruling request as a basis to define its practice with regards to stamp duty on the issuance of Asset Tokens and with...

ICO: Tax ruling from Zug tax authorities obtained

Prior to an ICO of one of our clients we have obtained a leading tax ruling related to the taxation of the proceeds from the ICO. In a nutshell, the respective proceeds will not be subject to corporate income tax in Switzerland....

You are currently offline. Some pages or content may fail to load.